2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $3.2B | $3.3B | $4.6B | $5.3B | $5.5B |
Cost of Revenue | $2.2B | $2.2B | $3.1B | $3.6B | $3.7B |
Gross Profit | $1.1B | $1.1B | $1.5B | $1.7B | $1.8B |
Gross Profit % | 33% | 32% | 32% | 32% | 32% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $23M | $106M | $273M | $333M | $276M |
Dep. & Amort. | $117M | $108M | $119M | $127M | $133M |
Def. Tax | $926K | -$10M | -$351K | $220K | $3.7M |
Stock Comp. | $9M | $13M | $17M | $22M | $22M |
Chg. in WC | $82M | -$71M | -$238M | -$54M | -$15M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $211M | $167M | $102M | $165M | $166M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $211M | $167M | $102M | $165M | $166M |
Receivables | $441M | $559M | $750M | $792M | $850M |
Inventory | $300M | $357M | $551M | $575M | $581M |
GMS reported Q3 FY25 results below expectations, with net sales of $1.3 billion (flat YoY), organic sales down 6.7%, and gross margin declining to 31.2% from 33% a year ago, primarily due to deteriorating demand, adverse weather, and holiday timing.
Commercial and multifamily end markets remain weak: U.S. commercial revenues were down 7.8% organically, multifamily wallboard volumes down 31.4%, and commercial wallboard volumes down 9.4%; office and high-rise mixed-use projects are particularly soft, while data centers, healthcare, and public education remain bright spots.
GMS is implementing an additional $20 million in annualized cost reductions (totaling $50 million since the start of FY25), with full run-rate expected in Q1 FY26; about half of these savings are structural and half are volume-related.
For Q4 FY25, GMS expects net sales to be down high single digits YoY (organic sales down low double digits), gross margin to remain around 31.2%, and adjusted EBITDA between $100–$110 million (margin ~8%); wallboard volumes are expected to be down mid-teens, with price/mix flat to slightly up.
Management believes the current period represents the bottom of the cycle, with improvement expected late in calendar 2025 or early 2026; long-term EBITDA margin target remains at 10%+, and the company continues to generate strong free cash flow (Q3 FCF was 89% of adjusted EBITDA).